The activation of both STING signaling pathways promotes type I IFN expression, enhances the natural and adaptive immune function of the body, and increases immune surveillance of tumor cells by the body which enhances the effect of immunotherapy (Liu et al., 2023). Here, STING1 is linked to neoplasm.